18-APR-2025 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1922-Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect 1 Y 1 Ramucirumab + Paclitaxel 54 21 3 1 1 0 0 06/01/2020 167 56
        2 FOLFIRI   20 6 1 0 0 0      
            41 9 2 1 0 0      
 
  S2001-Rando II, Mets Pancreas , BRCA1/2, Comb Chemo 1 Y 1 Olaparib + Pembrolizumab 88 33 11 4 3 0 0 02/22/2021 168 73
        2 Olaparib   34 9 4 1 0 0      
            67 20 8 4 0 0      
 
  S2104-Panc,Resect High-risk,Postop Adj Chemo vs Obs 1 Y 1 Capecitabine Temozolomide 154 40 14 5 4 1 0 05/05/2022 223 78
        2 Observation   26 11 7 6 1 1      
            66 25 12 10 2 1      
 
  S2303-Gas/Esoph/GEJ, Adv, Ram + Pac +/- Nivo 1 Y 1 Nivolumab + Paclitaxel + Ramucirumab 224 13 13 12 7 3 1 06/24/2024 230 89
        2 Paclitaxel + Ramucirumab   14 14 10 7 5 1      
            27 27 22 14 8 2      
 
Yes A021806-Pancreas, Perioperative vs Adjuvant Chemo 0 E Total Registrations   40 5 3 2 0 0 10/08/2020 261 115
            40 5 3 2 0 0      
 
    1 E Total Registrations   33 4 2 2 1 0 10/08/2020    
            33 4 2 2 1 0      
 
  A022102-Gastric, FOLFIRINOX +/-Nivo vs FOLFOX +/ Nivo 1 E Total Registrations   27 17 6 1 1 0 05/15/2023 251 105
            27 17 6 1 1 0      
 
  A022104-Rectal, Loc Adv, Triplet vs Doublet Chemo 1 E Total Registrations   95 44 24 9 3 1 03/13/2023 332 135
            95 44 24 9 3 1      
 
  EA2174-Esoph, Peri-Op Nivolumab +/- Ipilimumab 1 E Total Registrations   6 0 0 0 0 0 06/01/2021 233 84
            6 0 0 0 0 0      
 
    2 E Total Registrations   3 0 0 0 0 0 06/01/2021    
            3 0 0 0 0 0      
 
  EA2192-Panc, APOLLO 0 E Total Registrations   8 4 3 1 1 0 12/07/2022 135 80
            8 4 3 1 1 0      
 
    1 E Total Registrations   5 3 2 1 1 0 12/07/2022    
            5 3 2 1 1 0      
 
  NRGGI008-Colon, Stg III, Adj Chemo 1 E Total Registrations   44 17 10 2 0 0 12/08/2022 464 194
            44 17 10 2 0 0      
 
    2 E Total Registrations   32 15 9 5 1 0 12/08/2022    
            32 15 9 5 1 0      
 
No A022101-Colorectal, Metastatic, Ablative Tx 0 E Total Registrations   2 2 1 1 0 0 07/12/2024 137 73
            2 2 1 1 0 0      
 
    1 E Total Registrations   1 1 1 1 0 0 07/12/2024    
            1 1 1 1 0 0      
 
  CCTGCO32-Rectal, Early Stg, Neoadj/Exc/Obs vs ChemRad 1 E Total Registrations   4 4 1 1 1 0 06/26/2024 112 40
            4 4 1 1 1 0      
 
  CCTGNE1-Midgut NET, Unresect, 177 Lut vs Ever 1 E Total Registrations   4 4 1 0 0 0 06/11/2024 48 16
            4 4 1 0 0 0      
 
  EA2197-Gal, Rando Perioperative TX 1 E Total Registrations   9 4 1 0 0 0 11/18/2021 146 67
            9 4 1 0 0 0      
 
  EA2222-Colorectal, Stg II-III, Hep Art Infusion 1 E Total Registrations   3 3 2 1 1 0 06/12/2024 52 33
            3 3 2 1 1 0      
 
  NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy 1 Y Total Registrations   15 0 0 0 0 0 04/18/2018 317 111
            15 0 0 0 0 0      
 
  NRGGI005-COLON,Stg IIA, ctDNA in Adjuvant Chemotherapy 1 Y Total Registrations   35 0 0 0 0 0 07/06/2020 399 154
            35 0 0 0 0 0      
 
  NRGGI006-Esophagus, Stg I-IVA, PBT vs IMRT 1 E Total Registrations   1 1 0 0 0 0 06/21/2024 20 4
            1 1 0 0 0 0      
 
    2 E Total Registrations   1 1 0 0 0 0 06/21/2024    
            1 1 0 0 0 0      
 

18-APR-2025 6:10

GI Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs
# of
CURR
IRBs
NRGGI008 Colon, Stg III, Adj Chemo 3 Randomization 10-Mar-22 464 194